Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuyuan Huoxue Decoction is a traditional Chinese medicine (TCM) formula originally recorded in the Medical Revelations (Yi Xue Fa Wei). It is primarily used to treat traumatic injuries, blood stasis, and pain in the chest and hypochondrium. The formula typically consists of eight herbs: Bupleurum chinense (Chai Hu), Angelica sinensis (Dang Gui), Trichosanthes kirilowii (Tian Hua Fen), Carthamus tinctorius (Hong Hua), Prunus persica (Tao Ren), Rheum officinale (Da Huang), Manis pentadactyla (Chuan Shan Jia - often substituted in modern practice), and Glycyrrhiza uralensis (Gan Cao). In clinical settings, it is being investigated for its efficacy in treating postoperative constipation following orthopedic surgeries, such as those for osteoporotic thoracolumbar fractures, by promoting gastrointestinal motility and reducing inflammatory responses associated with surgical trauma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuyuan huoxue decoction.